Deep Medicine Acquisition Corp.

DMAQ · NASDAQ
Analyze with AI
12/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Activities
Net Income-$8,795-$400-$414
Dep. & Amort.$640$0$0
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$0$1,188-$288
Other Non-Cash$0-$1,824$4
Operating Cash Flow-$3,996-$1,036-$698
Investing Activities
PP&E Inv.-$36$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$2,479$0$0
Other Inv. Act.-$1,701$120,425-$127,765
Investing Cash Flow$741$120,425-$127,765
Financing Activities
Debt Repay.$0$0$0
Stock Issued$1$0$129,165
Stock Repurch.$0-$121,035$0
Dividends Paid$0$0$0
Other Fin. Act.$8,738-$119,670$128,840
Financing Cash Flow$8,739-$119,670$128,840
Forex Effect$0$0$0
Net Chg. in Cash$5,485-$282$377
Supplemental Information
Beg. Cash$5,398$877$500
End Cash$10,882$596$877
Free Cash Flow-$4,032-$1,036-$698
Deep Medicine Acquisition Corp. (DMAQ) Financial Statements & Key Stats | AlphaPilot